4.8 Article

CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 121, 期 10, 页码 3965-3980

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI58552

关键词

-

资金

  1. NIH [DK073495, DK089394, T32DK007540, DK087985]
  2. German Academic Exchange Service
  3. Swiss National Science Foundation [PBZHP3-128278]
  4. Amgen-FROMO
  5. NephCure foundation
  6. Katz Family Fund
  7. Swiss National Science Foundation (SNF) [PBZHP3-128278] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

Kidney podocytes are highly differentiated epithelial cells that form interdigitating foot processes with bridging slit diaphragms (SDs) that regulate renal ultrafiltration. Podocyte injury results in proteinuric kidney disease, and genetic deletion of SD-associated CD2-associated protein (CD2AP) leads to progressive renal failure in mice and humans. Here, we have shown that CD2AP regulates the TGF-beta 1-dependent translocation of dendrin from the SD to the nucleus. Nuclear dendrin acted as a transcription factor to promote expression of cytosolic cathepsin L (CatL). CatL proteolyzed the regulatory GTPase dynamin and the actin-associated adapter synaptopodin, leading to a reorganization of the podocyte microfilament system and consequent proteinuria. CD2AP itself was proteolyzed by CatL, promoting sustained expression of the protease during podocyte injury, and in turn increasing the apoptotic susceptibility of podocytes to TGF-beta 1. Our study identifies CD2AP as the gatekeeper of the podocyte TGF-beta response through its regulation of CatL expression and defines a molecular mechanism underlying proteinuric kidney disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据